Breaking News

Swype Shield cold and flu prevention product

November 4, 2013

It’s a clear gel that battles the common cold, but it isn’t hand sanitizer. Instead, Swype Shield, billed as physician-invented cold and flu prevention product, is applied on the nostrils, which is where cold and flu viruses most often enter the body.  The firm behind the product, Nuance Health, LLC, contends the formulation killed more than 99% of 25 cold and flu viruses in lab testing.

The active ingredients in Swype Shield are non-toxic and safe to apply to the skin multiple times a day. And Nuance Health, LLC notes ingredients used can be found in other skin-cleaning products.

Swype Shield is sold online for $8.99 per tube. 
blog comments powered by Disqus
  • Kitchen Counter Cosmetics

    Kitchen Counter Cosmetics

    Christine Esposito, Associate Editor||May 2, 2016
    LOLI box marks the convergence of natural and organic ingredients, subscription service and DIY cosmetic chemistry.

  • What’s New at La Prairie?

    What’s New at La Prairie?

    Melissa Meisel, Associate Editor||April 25, 2016
    VP of marketing shares the latest buzz with Happi.

  • Mapping Out Multicultural Beauty

    Mapping Out Multicultural Beauty

    April 25, 2016
    Agnieszka Saintemarie of Kline Group about current trends and challenges in multicultural beauty.

  • Erasing the Signs of Aging

    Pauline Rouaud-Tinguely, David Boudier, Sylvain Mazalrey, Jenny Laumonier, Isabelle Cruz, Gu00e9raldine Bon, Karine Perrinet, Bu00e9ranger Tassy, Brigitte Closs, Silab R&D, Saint-Viance, France||May 2, 2016
    Silab researchers explain how by acting on the endogenous hyaluronic acid pathway.

  • I Want It All

    I Want It All

    Melissa Meisel , Associate Editor||May 2, 2016
    Skin care moves beyond the basics with pampering formulations with unique components and novel functions.

  • Wacker Builds on Its Success

    Wacker Builds on Its Success

    Tom Branna, Editorial Director ||May 2, 2016
    The silicone maker had a good 2015 and expects the gains to continue in 2016, driven, in part, by success in the Americas and